WO2008005371A3 - Poly(orthoester) polymers, and methods of making and using same - Google Patents

Poly(orthoester) polymers, and methods of making and using same Download PDF

Info

Publication number
WO2008005371A3
WO2008005371A3 PCT/US2007/015197 US2007015197W WO2008005371A3 WO 2008005371 A3 WO2008005371 A3 WO 2008005371A3 US 2007015197 W US2007015197 W US 2007015197W WO 2008005371 A3 WO2008005371 A3 WO 2008005371A3
Authority
WO
WIPO (PCT)
Prior art keywords
orthoester
poly
polymers
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/015197
Other languages
French (fr)
Other versions
WO2008005371A2 (en
Inventor
Julie A Alkatout
Michael Eric Benz
Randall V Sparer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority to EP07810077A priority Critical patent/EP2044142A2/en
Publication of WO2008005371A2 publication Critical patent/WO2008005371A2/en
Publication of WO2008005371A3 publication Critical patent/WO2008005371A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/18—Block or graft polymers
    • C08G64/183—Block or graft polymers containing polyether sequences

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

Poly(orthoester) polymers, and methods of making and using such poly(orthoester) polymers are provided. The poly(orthoester) poylmers can be useful for applications including, for example, medical devices and pharmaceutical compositions. In a preferred embodiment, the poly(orthoester) polymers are biodegradable.
PCT/US2007/015197 2006-06-29 2007-06-29 Poly(orthoester) polymers, and methods of making and using same Ceased WO2008005371A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07810077A EP2044142A2 (en) 2006-06-29 2007-06-29 Poly(orthoester) polymers, and methods of making and using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81756006P 2006-06-29 2006-06-29
US60/817,560 2006-06-29

Publications (2)

Publication Number Publication Date
WO2008005371A2 WO2008005371A2 (en) 2008-01-10
WO2008005371A3 true WO2008005371A3 (en) 2008-04-10

Family

ID=38720422

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/015197 Ceased WO2008005371A2 (en) 2006-06-29 2007-06-29 Poly(orthoester) polymers, and methods of making and using same

Country Status (3)

Country Link
US (3) US7875697B2 (en)
EP (1) EP2044142A2 (en)
WO (1) WO2008005371A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2044142A2 (en) * 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
JP5297655B2 (en) * 2007-01-16 2013-09-25 富士フイルム株式会社 New fluoropolymer
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US9132119B2 (en) * 2008-04-18 2015-09-15 Medtronic, Inc. Clonidine formulation in a polyorthoester carrier
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
DE102008037201A1 (en) * 2008-08-11 2010-04-15 Alfred Buck Artificial joint
US9410016B2 (en) 2013-07-16 2016-08-09 Dow Global Technologies Llc Aromatic polyacetals and articles comprising them
US8962779B2 (en) * 2013-07-16 2015-02-24 Dow Global Technologies Llc Method of forming polyaryl polymers
US9063420B2 (en) 2013-07-16 2015-06-23 Rohm And Haas Electronic Materials Llc Photoresist composition, coated substrate, and method of forming electronic device
WO2015103319A1 (en) * 2013-12-31 2015-07-09 Heron Therapeutics, Inc. Polymer-based compositions for extended release of proteins
CN103804693B (en) * 2014-01-24 2016-03-09 中国科学院化学研究所 Dendroid polyketals and its preparation method and application
CA3174824A1 (en) * 2014-04-21 2015-10-29 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
HUE052224T2 (en) 2014-04-21 2021-04-28 Heron Therapeutics Inc Preparations of polyorthoester and organic acid excipients
CN106800651B (en) * 2017-01-22 2019-06-25 安徽大学 Polymer POEHD with pH and reduction responsiveness, and preparation method and application thereof
CN108144067B (en) * 2017-12-27 2020-11-24 安徽大学 Tetravalent platinum compound-bicyclic double bond amphiphilic polymer prodrug, nanomicelle, preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957856A (en) * 1958-08-29 1960-10-25 Union Carbide Corp Phosphorus-containing spirobi(metadioxane) resins
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4066747A (en) * 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
US4186185A (en) * 1976-04-08 1980-01-29 Alza Corporation Compositions comprising arylene substituted poly(orthoesters) containing useful agents
US4070347A (en) * 1976-08-16 1978-01-24 Alza Corporation Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4489056A (en) 1982-06-30 1984-12-18 Merck & Co., Inc. Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
US4513143A (en) 1982-12-01 1985-04-23 Sri International Preparation of ketene acetals
US4532335A (en) 1983-03-07 1985-07-30 Sri International Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
US4639366A (en) 1984-06-06 1987-01-27 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4765973A (en) 1984-06-06 1988-08-23 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4549010A (en) 1984-06-27 1985-10-22 Merck & Co., Inc. Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
US4638045A (en) 1985-02-19 1987-01-20 Massachusetts Institute Of Technology Non-peptide polyamino acid bioerodible polymers
CA1273872A (en) 1985-05-10 1990-09-11 Larry J. Caldwell Drug delivery device which can be retained in the stomach for a controlled period of time
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
CA1276556C (en) 1985-07-08 1990-11-20 Kenneth J. Himmelstein Organic acid as catalysts for the erosion of polymers
US4780319A (en) 1985-07-08 1988-10-25 Merck & Co., Inc. Organic acids as catalysts for the erosion of polymers
US4764364A (en) 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4855132A (en) 1986-02-25 1989-08-08 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4898928A (en) 1988-03-07 1990-02-06 Sandoz Pharmaceuticals Corp. Polyacetal and polyketal hydrogels formed from acetals or ketals and polyols
US4957998A (en) 1988-08-22 1990-09-18 Pharmaceutical Delivery Systems, Inc. Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages
US5108755A (en) 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US5013821A (en) 1989-06-15 1991-05-07 Pharmaceutical Delivery Systems, Inc. Ortho and thio-ortho ester polymer
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
JPH05502465A (en) 1989-08-28 1993-04-28 ファーマスーティカル　デリバリー　システムズ Biodegradable polymers useful for controlled release of therapeutic agents
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5211951A (en) 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
US5254345A (en) * 1991-10-11 1993-10-19 Merck & Co., Inc. Poly(orthocarbonate acetal) bioerodible polymers
DE4142130A1 (en) * 1991-12-20 1993-06-24 Basf Ag USE OF POLYACETALES BASED ON VINYL ETHERS AND DIHYDROXY COMPOUNDS IN WASHING AND CLEANING AGENTS AND POLYACETALES
NZ249770A (en) 1992-02-28 1996-09-25 Univ Texas Biodegradable, polymerisable, substantially water soluble macromer comprising at least one water soluble region, at least one degradable region and at least two free radical polymerisable regions separated by at least one degradable region
US5461140A (en) 1992-04-30 1995-10-24 Pharmaceutical Delivery Systems Bioerodible polymers for solid controlled release pharmaceutical compositions
US5700485A (en) 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
EP1132080A3 (en) 1992-09-10 2001-10-17 Children's Medical Center Corporation Biodegradable polymer matrices for sustained delivery of local anesthetic agents
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
HUP9700322A3 (en) 1995-06-09 2001-03-28 Euro Celtique Sa Formulations and methods for providing prolonged local anesthesia
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
AU1527097A (en) 1996-01-05 1997-08-01 Advanced Polymer Systems Inc. Polymers with controlled physical state and bioerodibility
NL1002427C2 (en) * 1996-02-23 1997-08-26 Akzo Nobel Nv Coating composition comprising a bicyclo or spiro-oester functional compound.
US5747060A (en) 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US6120491A (en) 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
US5919473A (en) 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
BR9815499A (en) 1997-07-02 2001-01-02 Euro Celtique Sa Prolonged anesthesia in joints and body spaces.
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US6133402A (en) 1998-08-04 2000-10-17 Cornell Research Foundation, Inc. Polycarbonates made using high activity catalysts
EP1225172B1 (en) * 1999-09-17 2004-07-21 Kansai Paint Co., Ltd. Polyorthoester and curable composition containing the same
EP1142596A1 (en) 2000-04-03 2001-10-10 Universiteit Gent Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
EP1280558B1 (en) 2000-05-11 2005-12-07 AP Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
JP2002035676A (en) * 2000-07-26 2002-02-05 Kansai Paint Co Ltd Coating finishing method
WO2002038185A2 (en) 2000-11-13 2002-05-16 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7767612B2 (en) * 2000-11-21 2010-08-03 Johnson Matthey Plc Esterification catalyst, polyester process and polyester article
EP1395626A1 (en) 2001-05-11 2004-03-10 AP Pharma, Inc. Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
US20030152630A1 (en) 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US20020176844A1 (en) 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US20040109893A1 (en) 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
AU2003258230A1 (en) 2002-08-13 2004-02-25 Medtronic, Inc Medical device exhibiting improved adhesion between polymeric coating and substrate
DE60316579T2 (en) 2002-08-13 2008-07-03 Medtronic, Inc., Minneapolis SYSTEM FOR THE DELIVERY OF ACTIVE SUBSTANCES WITH A HYDROPHOBIC CELLULOSE DERIVATIVE
US20040033251A1 (en) 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery system including a polyurethane, medical device, and method
WO2004014451A1 (en) 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery systems, medical devices, and methods
EP1531875B1 (en) 2002-08-13 2010-03-03 Medtronic, Inc. Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method
WO2004014448A1 (en) 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
US7045589B2 (en) * 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
US6863782B2 (en) 2002-11-15 2005-03-08 A.P. Pharma, Inc. Method of preparing di(ketene acetals)
US7288609B1 (en) * 2003-03-04 2007-10-30 Advanced Cardiovascular Systems, Inc. Coatings for drug delivery devices based on poly (orthoesters)
US6982338B2 (en) * 2003-05-06 2006-01-03 National Starch And Chemical Investment Holding Corporation Oxetane compounds containing maleimide functionality
DK1635787T3 (en) * 2003-06-26 2012-03-26 Control Delivery Sys Inc Bioerodible delayed release drug delivery systems
EP1660145A2 (en) 2003-08-13 2006-05-31 Medtronic, Inc. Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices and methods
US20050064005A1 (en) 2003-08-13 2005-03-24 Dinh Thomas Q. Active agent delivery systems including a miscible polymer blend, medical devices, and methods
DE102004003495A1 (en) * 2004-01-23 2005-08-11 Bayer Materialscience Ag Orthoestergruppenhaltige binder
US20050209433A1 (en) * 2004-03-22 2005-09-22 Barsotti Robert J Orthoester-protected polyols for low VOC coatings
CN101426529A (en) * 2005-03-31 2009-05-06 阿帕医药有限公司 PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
DE102005018909A1 (en) * 2005-04-22 2006-10-26 Degussa Ag Process for the preparation of unsaturated, cyclic orthoesters
WO2007098041A1 (en) * 2006-02-17 2007-08-30 Medtronic, Inc. Polyketal polymers, and methods of making and using same
EP2044142A2 (en) * 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
US7927620B2 (en) * 2007-05-15 2011-04-19 Boston Scientific Scimed, Inc. Medical devices having antifouling character
US8531978B2 (en) * 2009-02-02 2013-09-10 Level 3 Communications, Llc Network cost analysis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups

Also Published As

Publication number Publication date
EP2044142A2 (en) 2009-04-08
WO2008005371A2 (en) 2008-01-10
US20080033140A1 (en) 2008-02-07
US7875697B2 (en) 2011-01-25
US20110082275A1 (en) 2011-04-07
US20120149864A1 (en) 2012-06-14
US8133968B2 (en) 2012-03-13

Similar Documents

Publication Publication Date Title
WO2006107903A3 (en) Polymeric micelles for drug delivery
WO2008100346A3 (en) N-substituted monomers and polymers
WO2008034013A3 (en) Medical devices and methods of making the same
WO2008057697A3 (en) Cross-linked polymer particles
WO2007147010A3 (en) Implantable medical devices and methods for making the same
IL189187A (en) Polymer conjugates of k-252a and derivatives thereof, pharmaceutical compositions comprising the same and uses thereof
WO2007121131A3 (en) Medical devices including shape memory materials
IL195488A (en) Compounds, pharmaceutical compositions comprising the same and uses thereof
WO2007148300A3 (en) Methods and systems for push-to-storage
EP1962906A4 (en) Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
IL203915A (en) 2-benzylphenyl-6-hydroxymethyl-tetrahydro-2h-pyran-3,4,5-triol derivatives and pharmaceutical compositions comprising the same
EP1998751A4 (en) Devices, systems and methods for medicament delivery
WO2008094834A3 (en) Multi-functional drug carriers
WO2008054676A3 (en) Medical devices and methods of using the same
WO2007127473A3 (en) Poly (ethylene glycol) containing chemically disparate endgroups
WO2008033300A3 (en) Bis (thiohydrazide amides) formulation
AU2003243750A1 (en) Rapidly dissolving micro-perforator for drug delivery and other applications
IL196426A0 (en) Microparticulates based on an amphiphilic copolymer, processes for the preparation thereof and pharmaceutical compositions containing the same
EP2026756A4 (en) Resorbable polymer compositions for use in medicine, dentistry, and surgery
WO2006099514A3 (en) Drug delivery compositions and related methods
EP1928930A4 (en) Polyalkylene glycol monomer, polyalkylene glycol polymer containing the same, and application thereof
WO2007112279A3 (en) Resonators
WO2007050294A3 (en) Liquid dosage forms having enteric properties of delayed and then sustained release
IL196866A (en) Erythropoietin molecules, pharmaceutical compositions comprising the same and uses thereof
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07810077

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007810077

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU